Further Information
NEDD9, neural precursor cell expressed, developmentally down-regulated 9, CAS-L, CASL, HEF1, dJ49G10.2, dJ761I2.1, Crk-associated substrate related, cas-like docking dJ49G10.2 (Enhancer of Filamentation 1 (HEF1)), dJ761I2.1 (enhancer of filamentation (HEF1)), enhancer of filamentation 1
Peptide ELISA: antibody detection limit dilution 1:8000.Western Blot:Approx 100kDa band observed in Human Kidney, Lung and Placenta lysates (calculated MW of 92.9kDa according to NP_006394.1). Recommended concentration: 0.1-0.3ug/ml.
- Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B, Brennan C, Hahn WC, Cordon-Cardo C, Wagner SN, Flotte TJ, Duncan LM, Granter SR, Chin L. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell. 2006 Jun 30;125(7):1269-81.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Mouse, Rat, Dog
The immunogen for this antibody is: NKPQNKCDDLDR
4739
neural precursor cell expressed, developmentally down-regulated 9
NEDD9
Homo sapiens
Liquid
NP_006394.1, NP_892011.2
5453680
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer
This antibody is expected to recognise isoform 1 (NP_006394.1) only.
Q14511